MedicarePartD.guide

A non-government resource built from CMS public data

Hepatitis C drugs on every 2026 Nevada Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 10 stand-alone Part D plans in Nevada cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days
Hepatitis C drugs by 2026 Nevada Part D plan
DrugHumana Basic Rx Plan$0.00/moS5884-112Wellcare Classic$2.70/moS4802-093Wellcare Value Script$2.70/moS4802-161Humana Value Rx Plan$43.70/moS5884-208HealthSpring Extra Rx$52.60/moS5617-379AARP Medicare Rx Saver from UHC$76.70/moS5921-373HealthSpring Assurance Rx$95.60/moS5617-143SilverScript Choice$97.40/moS5601-058AARP Medicare Rx Preferred from UHC$139.10/moS5921-410Humana Premier Rx Plan$148.70/moS5884-175
Epclusasofosbuvir and velpatasvirTier 5PA25%QL 28/28dNot coveredNot coveredTier 5PA26%QL 28/28dTier 5PA25%QL 28/28dNot coveredTier 5PA25%QL 28/28dTier 5PA25%Not coveredTier 5PA33%QL 28/28d
sofosbuvir-velpatasvirgeneric EpclusaNot coveredTier 5PA25%QL 28/28dTier 5PA25%QL 28/28dNot coveredNot coveredTier 5PA25%QL 28/28dNot coveredNot coveredTier 5PA31%QL 28/28dNot covered
Mavyretglecaprevir and pibrentasvirNot coveredNot coveredNot coveredNot coveredNot coveredTier 5PA25%QL 140/28dNot coveredTier 5PA25%Tier 5PA31%QL 140/28dNot covered
Harvoniledipasvir and sofosbuvirNot coveredNot coveredNot coveredNot coveredTier 5PA25%QL 28/28dNot coveredTier 5PA25%QL 28/28dNot coveredNot coveredNot covered
ledipasvir-sofosbuvirgeneric HarvoniNot coveredTier 5PA25%QL 28/28dTier 5PA25%QL 28/28dNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
VosevisofosbuvirTier 5PA25%QL 28/28dNot coveredNot coveredTier 5PA26%QL 28/28dTier 5PA25%QL 28/28dTier 5PA25%QL 28/28dTier 5PA25%QL 28/28dTier 5PA25%QL 28/28dTier 5PA31%QL 28/28dTier 5PA33%QL 28/28d

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.